688177.SS
Latest Trade
23.81CNYChange
0.34(+1.45%)Volume
1,234,125Today's Range
-
24.2852 Week Range
-
73.99As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 23.47 |
|---|---|
Open | 23.33 |
Volume | 1,234,125 |
3M AVG Volume | 26.19 |
Today's High | 24.28 |
Today's Low | 23.33 |
52 Week High | 73.99 |
52 Week Low | 21.82 |
Shares Out (MIL) | 414.08 |
Market Cap (MIL) | 9,718.46 |
Forward P/E | -- |
Dividend (Yield %) | -- |
Biogen And Bio-Thera Solutions Announce Commercialization And License Agreement For Proposed Biosimilar Currently In Phase 3 With Potential To Treat Moderate To Severe Rheumatoid Arthritis
Bio-Thera Solutions' 2020 Net Loss Narrows To 513.2 Mln Yuan
Bio-Thera Solutions' Prelim 2020 Net Loss Narrows
Bio-Thera Solutions, Ltd. is a China-based company mainly engaged in the research and development of innovative drugs and biosimilars. The Company is committed to the development of a new generation of antibody drugs to treat cancer, autoimmune diseases, cardiovascular diseases and other major diseases that endanger human life and health. The Company's main products include adalimumab BAT1406, bevacizumab BAT1706, BAT8001, tocilizumab BAT1806, batifaban BAT2094, BAT8003 and so on.
Industry
Biotechnology & Drugs
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 52.54 |
Price To Book (MRQ) | 4.85 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 0.00 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | -38.86 |
Return on Equity (TTM) | -30.12 |
* SAYS H1 NET LOSS NARROWS TO 243.8 MILLION YUAN ($35.41 million) FROM 715.1 MILLION YUAN YEAR EARLIER Source text in Chinese: https://bit.ly/34Ep88u Further company coverage: ($1 = 6.8841 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)
* SAYS IT PLANS TO ISSUE H-SHARES AND LIST IN HONG KONG STOCK EXCHANGE Source text in Chinese: https://bit.ly/3d6AJhl Further company coverage: (Reporting by Hong Kong newsroom)
* SAYS 2019 NET LOSS WIDENS TO 1.0 BILLION YUAN ($141.33 million) FROM 553.1 MILLION YUAN YEAR EARLIER
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.